报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2025-03-31 | -3.94% | 7.08% | 85.05% | 137/158 | -0.37% | 华特达因 | 10.79% | 行业排名> |
2024-12-31 | -26.35% | -11.98% | -69.67% | 139/158 | -9.52% | 翰宇药业 | 11.39% | 行业排名> |
2024-09-30 | -15.53% | 0.7% | -11.57% | 144/158 | 4.23% | 百利天恒 | 181.27% | 行业排名> |
2024-06-30 | -13.92% | -18.07% | -228.3% | 145/158 | 2.66% | 百利天恒 | 186.1% | 行业排名> |
2024-03-31 | -4.24% | 8.42% | 81.98% | 139/158 | 2.32% | 百利天恒 | 186.89% | 行业排名> |
2023-12-31 | -23.53% | -0.38% | -50.45% | 137/158 | -1.03% | 百利天恒 | 188.56% | 行业排名> |
2023-09-30 | -15.64% | -18.66% | -32.65% | 140/158 | 2.34% | 小方制药 | 41.8% | 行业排名> |
2023-06-30 | -11.79% | -41.88% | -154.64% | 139/158 | 1.46% | 拓新药业 | 20.51% | 行业排名> |
2023-03-31 | -4.63% | -40.73% | 80.25% | 137/158 | 1.37% | 拓新药业 | 19.87% | 行业排名> |
2022-12-31 | -23.44% | -50.45% | -77.85% | 136/158 | 0.67% | 拓新药业 | 19.91% | 行业排名> |
2022-09-30 | -13.18% | -52.37% | -58.6% | 133/158 | 2.8% | 小方制药 | 55.57% | 行业排名> |
2022-06-30 | -8.31% | -50% | -152.58% | 138/158 | 2.16% | 福元医药 | 25.41% | 行业排名> |
2022-03-31 | -3.29% | -55.92% | 78.88% | 129/158 | 1.57% | 小方制药 | 34.81% | 行业排名> |
2021-12-31 | -15.58% | 47.72% | -80.12% | 134/158 | 0.75% | 退市金泰 | 10.74% | 行业排名> |
2021-09-30 | -8.65% | 72.11% | -56.14% | 126/158 | 4.43% | 人福医药 | 6.82% | 行业排名> |
2021-06-30 | -5.54% | 70.41% | -162.56% | 132/158 | 2.94% | 小方制药 | 71.99% | 行业排名> |
2021-03-31 | -2.11% | 70.53% | 92.92% | 119/158 | 2.49% | 汇宇制药 | 39.25% | 行业排名> |
2020-12-31 | -29.8% | 6.58% | 3.93% | 136/158 | 3.58% | 汇宇制药 | 28.14% | 行业排名> |
2020-09-30 | -31.02% | 2% | -65.71% | 115/158 | 3.03% | 哈三联 | 27.17% | 行业排名> |
2020-06-30 | -18.72% | 2% | 41.32% | 127/158 | 4.19% | 汇宇制药 | 55.94% | 行业排名> |
2019-12-31 | -31.9% | -1.98% | -345.53% | 127/158 | 2.53% | 河化股份 | 45.32% | 行业排名> |
2019-03-31 | -7.16% | 2% | 77.11% | 106/158 | 2.41% | 汇宇制药 | 31.9% | 行业排名> |
2018-12-31 | -31.28% | -357.31% | -357.31% | 131/158 | 6.99% | 誉衡药业 | 35.56% | 行业排名> |
2015-12-31 | -6.84% | -52% | -52% | 99/158 | 11.27% | 奥赛康 | 35% | 行业排名> |